Krzysztof Chmura
Krzysztof Chmura has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adrianna Alicja Piekarska
University Clinical Centre, Gdansk, Poland
10 shared publications - Andrzej Józef Horabik
Polish Red Cross Maritime Hospital, Gdynia, Poland
10 shared publications - Gabriela Kryger
University Clinical Centre, Gdansk, Poland
10 shared publications - Julia Hertmanowska
University Clinical Centre, Gdansk, Poland
10 shared publications - Magdalena Wiśniewska
St. Vincent de Paul Municipal Hospital, Gdynia, Poland
10 shared publications - Marta Piotrowska
St. Vincent de Paul Municipal Hospital, Gdynia, Poland
10 shared publications
Latest Publications
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
ARTHROSCOPY-ASSISTED VERSUS CONVENTIONAL FIXATION OF INTRA-ARTICULAR FRACTURES: A NARRATIVE REVIEW OF JOINT-SPECIFIC OUTCOMES
Arthroscopy-assisted fracture fixation has increasingly been adopted as an adjunct to conventional open reduction and internal fixation (ORIF) in the management of intra-articular fractures. While ORIF remains the standard surgical approach, arthroscopy enables direct visualization of articular surfaces and associated intra-articular pathology, potentially improving reduction accuracy and clinical outcomes. This narrative review compares functional and clinical outcomes of conventional fixation techniques with arthroscopy-assisted approaches across multiple joints, including the ankle, knee (tibial plateau), wrist (distal radius), and elbow. A comprehensive literature search was conducted using PubMed and supplemented by systematic reviews from Embase and Cochrane databases. Current evidence demonstrates that arthroscopy-assisted fixation provides joint- and fracture-specific advantages, particularly in ankle fractures, Schatzker I–III tibial plateau fractures, and complete intra-articular distal radius fractures. Evidence for elbow fractures remains limited but suggests potential benefits in carefully selected cases. Arthroscopy-assisted fixation should be considered a complementary technique and applied selectively based on fracture morphology, joint involved, and surgeon expertise.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Open AccessARTHROSCOPY-ASSISTED VERSUS CONVENTIONAL FIXATION OF INTRA-ARTICULAR FRACTURES: A NARRATIVE REVIEW OF JOINT-SPECIFIC OUTCOMES
Arthroscopy-assisted fracture fixation has increasingly been adopted as an adjunct to conventional open reduction and internal fixation (ORIF) in the management of intra-articular fractures. While ORIF remains the standard surgical approach, arthroscopy enables direct visualization of articular surfaces and associated intra-articular pathology, potentially improving reduction accuracy and clinical outcomes. This narrative review compares functional and clinical outcomes of conventional fixation techniques with arthroscopy-assisted approaches across multiple joints, including the ankle, knee (tibial plateau), wrist (distal radius), and elbow. A comprehensive literature search was conducted using PubMed and supplemented by systematic reviews from Embase and Cochrane databases. Current evidence demonstrates that arthroscopy-assisted fixation provides joint- and fracture-specific advantages, particularly in ankle fractures, Schatzker I–III tibial plateau fractures, and complete intra-articular distal radius fractures. Evidence for elbow fractures remains limited but suggests potential benefits in carefully selected cases. Arthroscopy-assisted fixation should be considered a complementary technique and applied selectively based on fracture morphology, joint involved, and surgeon expertise.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
LIVER RESECTION VERSUS RADIOFREQUENCY ABLATION FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA: AN EVIDENCE-BASED NARRATIVE REVIEW OF ONCOLOGICAL OUTCOMES AND TREATMENT SELECTION
Background: Surgical resection (LR) and radiofrequency ablation (RFA) are established curative options for early-stage hepatocellular carcinoma (HCC), yet their relative benefits remain debated, particularly regarding long-term survival, recurrence control, and patient selection. Objectives: To synthesize contemporary evidence comparing liver resection and radiofrequency ablation for early-stage HCC, with a focus on oncological outcomes, recurrence patterns, perioperative safety, and clinically relevant subgroups. Methods: An evidence-based narrative review was conducted using structured searches of PubMed/MEDLINE and the Cochrane Library. Systematic reviews, meta-analyses, randomized controlled trials, and high-quality observational studies comparing LR and RFA in early-stage HCC were included. Outcomes of interest comprised overall survival (OS), recurrence-free or disease-free survival (RFS/DFS), tumor recurrence, perioperative morbidity, and cost-effectiveness. Findings were synthesized qualitatively. Results: Randomized controlled trials consistently demonstrated no statistically significant difference in overall survival between LR and RFA. In contrast, meta-analyses and propensity-adjusted observational studies suggested improved long-term survival following resection in selected patients with preserved liver function. Across comparative studies, recurrence-free survival and local tumor control consistently favored resection. Subgroup analyses indicated comparable survival outcomes between modalities in patients with very small tumors, impaired hepatic reserve (Child–Pugh class B), and elderly populations, while tumor size and anatomical location emerged as key modifiers of treatment efficacy. Conclusions: Liver resection provides superior local tumor control, whereas overall survival remains largely comparable between modalities in carefully selected patients. Treatment selection should be individualized, integrating tumor characteristics, liver function, patient comorbidities, and procedural risk within a multidisciplinary framework.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessLIVER RESECTION VERSUS RADIOFREQUENCY ABLATION FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA: AN EVIDENCE-BASED NARRATIVE REVIEW OF ONCOLOGICAL OUTCOMES AND TREATMENT SELECTION
Background: Surgical resection (LR) and radiofrequency ablation (RFA) are established curative options for early-stage hepatocellular carcinoma (HCC), yet their relative benefits remain debated, particularly regarding long-term survival, recurrence control, and patient selection. Objectives: To synthesize contemporary evidence comparing liver resection and radiofrequency ablation for early-stage HCC, with a focus on oncological outcomes, recurrence patterns, perioperative safety, and clinically relevant subgroups. Methods: An evidence-based narrative review was conducted using structured searches of PubMed/MEDLINE and the Cochrane Library. Systematic reviews, meta-analyses, randomized controlled trials, and high-quality observational studies comparing LR and RFA in early-stage HCC were included. Outcomes of interest comprised overall survival (OS), recurrence-free or disease-free survival (RFS/DFS), tumor recurrence, perioperative morbidity, and cost-effectiveness. Findings were synthesized qualitatively. Results: Randomized controlled trials consistently demonstrated no statistically significant difference in overall survival between LR and RFA. In contrast, meta-analyses and propensity-adjusted observational studies suggested improved long-term survival following resection in selected patients with preserved liver function. Across comparative studies, recurrence-free survival and local tumor control consistently favored resection. Subgroup analyses indicated comparable survival outcomes between modalities in patients with very small tumors, impaired hepatic reserve (Child–Pugh class B), and elderly populations, while tumor size and anatomical location emerged as key modifiers of treatment efficacy. Conclusions: Liver resection provides superior local tumor control, whereas overall survival remains largely comparable between modalities in carefully selected patients. Treatment selection should be individualized, integrating tumor characteristics, liver function, patient comorbidities, and procedural risk within a multidisciplinary framework.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
BIOLOGIC AND TARGETED THERAPIES IN ATOPIC DERMATITIS: A BIOMARKER-INFORMED FRAMEWORK FOR PERSONALIZED TREATMENT SELECTION
Background: Atopic dermatitis is a chronic inflammatory skin disease characterized by pruritus, eczematous lesions, and impaired quality of life. Advances in understanding type 2 immune dysregulation have led to the development of biologic and targeted systemic therapies; however, treatment response remains heterogeneous, highlighting the need for personalized therapeutic strategies. Objective: To review current biologic and targeted systemic therapies for moderate-to-severe atopic dermatitis, examine the role of clinical and molecular biomarkers in predicting treatment response, and propose a biomarker-informed framework for personalized treatment selection. Methods: A narrative review was conducted of literature published between January 2020 and July 2024 using major scientific databases. Included publications comprised randomized controlled trials, cohort studies, systematic reviews, and expert consensus documents addressing systemic therapies, biomarker associations, and stratified treatment approaches in atopic dermatitis. Results: Biologic agents, including dupilumab, tralokinumab, lebrikizumab, and nemolizumab, are associated with substantial improvements in skin inflammation and pruritus and demonstrate favorable safety profiles across diverse patient populations. Janus kinase inhibitors provide rapid symptom control but require careful patient selection due to safety considerations. Biomarkers such as thymus and activation-regulated chemokine, eotaxin-3, periostin, eosinophil count, and interleukin-13 gene expression contribute to the characterization of disease endotypes and may support biologically informed treatment decisions. Conclusions: Biologic and targeted systemic therapies have transformed the management of atopic dermatitis; however, optimal outcomes depend on individualized treatment selection. Biomarker-informed approaches offer a rational framework to reduce empirical treatment cycling and advance precision medicine in atopic dermatitis, although further validation in real-world clinical settings is required.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessBIOLOGIC AND TARGETED THERAPIES IN ATOPIC DERMATITIS: A BIOMARKER-INFORMED FRAMEWORK FOR PERSONALIZED TREATMENT SELECTION
Background: Atopic dermatitis is a chronic inflammatory skin disease characterized by pruritus, eczematous lesions, and impaired quality of life. Advances in understanding type 2 immune dysregulation have led to the development of biologic and targeted systemic therapies; however, treatment response remains heterogeneous, highlighting the need for personalized therapeutic strategies. Objective: To review current biologic and targeted systemic therapies for moderate-to-severe atopic dermatitis, examine the role of clinical and molecular biomarkers in predicting treatment response, and propose a biomarker-informed framework for personalized treatment selection. Methods: A narrative review was conducted of literature published between January 2020 and July 2024 using major scientific databases. Included publications comprised randomized controlled trials, cohort studies, systematic reviews, and expert consensus documents addressing systemic therapies, biomarker associations, and stratified treatment approaches in atopic dermatitis. Results: Biologic agents, including dupilumab, tralokinumab, lebrikizumab, and nemolizumab, are associated with substantial improvements in skin inflammation and pruritus and demonstrate favorable safety profiles across diverse patient populations. Janus kinase inhibitors provide rapid symptom control but require careful patient selection due to safety considerations. Biomarkers such as thymus and activation-regulated chemokine, eotaxin-3, periostin, eosinophil count, and interleukin-13 gene expression contribute to the characterization of disease endotypes and may support biologically informed treatment decisions. Conclusions: Biologic and targeted systemic therapies have transformed the management of atopic dermatitis; however, optimal outcomes depend on individualized treatment selection. Biomarker-informed approaches offer a rational framework to reduce empirical treatment cycling and advance precision medicine in atopic dermatitis, although further validation in real-world clinical settings is required.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
HEALTHCARE COSTS ACROSS THE BODY MASS INDEX SPECTRUM: THE ROLE OF AGE AND MULTIMORBIDITY — A SYSTEMATIC REVIEW
Background: Body mass index (BMI) is widely used to classify nutritional status and assess health risk at the population level. Both low and high BMI values are associated with adverse health outcomes; however, the economic consequences of abnormal BMI across the full BMI spectrum have not been comprehensively synthesized in recent literature. Objective: To systematically review evidence published since 2015 on healthcare costs associated with BMI categories ranging from underweight to severe obesity, with particular attention to the modifying roles of age and multimorbidity. Methods: A systematic literature search was conducted in PubMed to identify studies published between January 2015 and March 2025 reporting healthcare costs stratified by BMI. Observational studies, cohort studies, registry-based analyses, and cost-of-illness studies were included. Due to substantial methodological heterogeneity, a narrative synthesis was performed. Results: Across healthcare systems, a consistent non-linear association between BMI and healthcare costs was observed. Normal BMI was associated with the lowest expenditures, while both underweight and obesity were linked to increased costs. Severe obesity generated the highest costs, largely driven by chronic disease burden and hospitalization. Age and multimorbidity substantially modified the BMI–cost relationship, with underweight particularly associated with prolonged hospitalization among older adults. Conclusions: Healthcare costs vary significantly across the BMI spectrum. Both extremes of BMI are associated with increased economic burden, underscoring the importance of age-sensitive and multimorbidity-informed prevention and care strategies.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessHEALTHCARE COSTS ACROSS THE BODY MASS INDEX SPECTRUM: THE ROLE OF AGE AND MULTIMORBIDITY — A SYSTEMATIC REVIEW
Background: Body mass index (BMI) is widely used to classify nutritional status and assess health risk at the population level. Both low and high BMI values are associated with adverse health outcomes; however, the economic consequences of abnormal BMI across the full BMI spectrum have not been comprehensively synthesized in recent literature. Objective: To systematically review evidence published since 2015 on healthcare costs associated with BMI categories ranging from underweight to severe obesity, with particular attention to the modifying roles of age and multimorbidity. Methods: A systematic literature search was conducted in PubMed to identify studies published between January 2015 and March 2025 reporting healthcare costs stratified by BMI. Observational studies, cohort studies, registry-based analyses, and cost-of-illness studies were included. Due to substantial methodological heterogeneity, a narrative synthesis was performed. Results: Across healthcare systems, a consistent non-linear association between BMI and healthcare costs was observed. Normal BMI was associated with the lowest expenditures, while both underweight and obesity were linked to increased costs. Severe obesity generated the highest costs, largely driven by chronic disease burden and hospitalization. Age and multimorbidity substantially modified the BMI–cost relationship, with underweight particularly associated with prolonged hospitalization among older adults. Conclusions: Healthcare costs vary significantly across the BMI spectrum. Both extremes of BMI are associated with increased economic burden, underscoring the importance of age-sensitive and multimorbidity-informed prevention and care strategies.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
OPEN VERSUS LAPAROSCOPIC NEPHRECTOMY FOR RENAL TUMORS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PERIOPERATIVE, FUNCTIONAL AND ONCOLOGIC OUTCOMES
Background: Renal tumors are increasingly detected early due to widespread imaging. For localized tumors, particularly stage T1, partial nephrectomy (PN) is the standard of care, offering oncological efficacy while preservingrenal function. Laparoscopic partial nephrectomy (LPN) has been increasingly adopted, yet comparative outcomes with open partial nephrectomy (OPN) remain actively evaluated. Aim: To systematically review perioperative, functional, and oncological outcomes of LPN versus OPN in patients with localized renal tumors, including the impact of tumor anatomical complexity. Materials and Methods: A systematic literature search of PubMed identified comparative studies of LPN versus OPN for T1–T1b renal tumors. Extracted data included operative time, estimated blood loss, complications, renalfunction, oncological outcomes, and tumor complexity assessed by nephrometry scores. Results: LPN showed perioperative advantages, including reduced blood loss and shorter hospital stay, with operative time generally comparable to OPN in experienced centers. Early and long-term renal function, measured by estimated glomerular filtration rate, was similar between approaches. Oncological outcomes, including positive surgical margins, recurrence-free survival, cancer-specific survival, and overall survival, were equivalent. In anatomically complex or selected T1b tumors, LPN achieved acceptable perioperative and oncological outcomes when performed in experienced centers. Conclusions: Laparoscopic partial nephrectomy is a safe and effective alternative to open surgery for localized renal tumors, offering perioperative benefits without compromising renal function or oncological control. Tumor complexity and patient characteristics are more influential determinants of outcomes than surgical approach. LPN should be considered a standard option in centers with expertise in minimally invasive nephron-sparing surgery.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessOPEN VERSUS LAPAROSCOPIC NEPHRECTOMY FOR RENAL TUMORS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PERIOPERATIVE, FUNCTIONAL AND ONCOLOGIC OUTCOMES
Background: Renal tumors are increasingly detected early due to widespread imaging. For localized tumors, particularly stage T1, partial nephrectomy (PN) is the standard of care, offering oncological efficacy while preservingrenal function. Laparoscopic partial nephrectomy (LPN) has been increasingly adopted, yet comparative outcomes with open partial nephrectomy (OPN) remain actively evaluated. Aim: To systematically review perioperative, functional, and oncological outcomes of LPN versus OPN in patients with localized renal tumors, including the impact of tumor anatomical complexity. Materials and Methods: A systematic literature search of PubMed identified comparative studies of LPN versus OPN for T1–T1b renal tumors. Extracted data included operative time, estimated blood loss, complications, renalfunction, oncological outcomes, and tumor complexity assessed by nephrometry scores. Results: LPN showed perioperative advantages, including reduced blood loss and shorter hospital stay, with operative time generally comparable to OPN in experienced centers. Early and long-term renal function, measured by estimated glomerular filtration rate, was similar between approaches. Oncological outcomes, including positive surgical margins, recurrence-free survival, cancer-specific survival, and overall survival, were equivalent. In anatomically complex or selected T1b tumors, LPN achieved acceptable perioperative and oncological outcomes when performed in experienced centers. Conclusions: Laparoscopic partial nephrectomy is a safe and effective alternative to open surgery for localized renal tumors, offering perioperative benefits without compromising renal function or oncological control. Tumor complexity and patient characteristics are more influential determinants of outcomes than surgical approach. LPN should be considered a standard option in centers with expertise in minimally invasive nephron-sparing surgery.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
FUSOBACTERIUM AS A POTENTIAL PATHOGENETIC FACTOR IN ENDOMETRIOSIS: CURRENT EVIDENCE, METHODOLOGICAL CHALLENGES, AND CLINICAL IMPLICATIONS
Background: Endometriosis is a chronic inflammatory gynecological disorder with an incompletely understood etiology. While hormonal, immunological, and genetic factors have been extensively studied, increasing attention has recently been directed toward the potential role of microbial agents in disease pathogenesis. Among these, Fusobacterium, particularly Fusobacterium nucleatum, has emerged as a candidate pathogen based on translational and experimental findings. Objective: This narrative review aims to critically evaluate current evidence regarding the association between Fusobacterium and endometriosis, assess the biological plausibility of a pathogenic role, and identify methodological limitations and clinical implications. Methods: A structured literature search was conducted in PubMed for publications addressing Fusobacterium in the context of endometriosis, including human studies, experimental models, and relevant commentaries. Evidence was synthesized thematically, with emphasis on study design, detection methods, and consistency of findings. Results: Available data suggest that Fusobacterium may be present in endometrial tissues of some women with endometriosis and may promote inflammatory signaling and lesion development in experimental models. However, recent human studies have reported conflicting results, including a lack of significant Fusobacterium enrichment in eutopic endometrium. These discrepancies appear to be influenced by differences in patient selection, sampling strategies, low-biomass contamination risk, and microbiological detection techniques. Conclusion: Although Fusobacterium represents a biologically plausible contributor to endometriosis pathophysiology, current evidence remains inconclusive. Further standardized, well-controlled studies are required before diagnostic or therapeutic strategies targeting this bacterium can be considered in clinical practice.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessFUSOBACTERIUM AS A POTENTIAL PATHOGENETIC FACTOR IN ENDOMETRIOSIS: CURRENT EVIDENCE, METHODOLOGICAL CHALLENGES, AND CLINICAL IMPLICATIONS
Background: Endometriosis is a chronic inflammatory gynecological disorder with an incompletely understood etiology. While hormonal, immunological, and genetic factors have been extensively studied, increasing attention has recently been directed toward the potential role of microbial agents in disease pathogenesis. Among these, Fusobacterium, particularly Fusobacterium nucleatum, has emerged as a candidate pathogen based on translational and experimental findings. Objective: This narrative review aims to critically evaluate current evidence regarding the association between Fusobacterium and endometriosis, assess the biological plausibility of a pathogenic role, and identify methodological limitations and clinical implications. Methods: A structured literature search was conducted in PubMed for publications addressing Fusobacterium in the context of endometriosis, including human studies, experimental models, and relevant commentaries. Evidence was synthesized thematically, with emphasis on study design, detection methods, and consistency of findings. Results: Available data suggest that Fusobacterium may be present in endometrial tissues of some women with endometriosis and may promote inflammatory signaling and lesion development in experimental models. However, recent human studies have reported conflicting results, including a lack of significant Fusobacterium enrichment in eutopic endometrium. These discrepancies appear to be influenced by differences in patient selection, sampling strategies, low-biomass contamination risk, and microbiological detection techniques. Conclusion: Although Fusobacterium represents a biologically plausible contributor to endometriosis pathophysiology, current evidence remains inconclusive. Further standardized, well-controlled studies are required before diagnostic or therapeutic strategies targeting this bacterium can be considered in clinical practice.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
THE IMPACT OF CHRONIC STRESS ON MENSTRUAL DISORDERS IN WOMEN OF REPRODUCTIVE AGE: A LITERATURE REVIEW
Chronic psychological and physical stress is a major contributor to menstrual disturbances in women of reproductive age. This review aims to synthesize current evidence on the mechanisms, clinical implications, and management of stress-related menstrual dysfunction, with particular focus on hypothalamic suppression. Methods included comprehensive evaluation of observational studies, clinical trials, and experimental research addressing neuroendocrine, metabolic, and behavioral pathways affected by prolonged stress, energy deficiency, and intensive physical activity. Findings indicate that chronic stress disrupts hormonal regulation by inhibiting gonadotropin secretion and impairing ovarian function, leading to reduced estrogen production and anovulation. Energy deficiency and excessive physical exertion exacerbate these effects, resulting in prolonged hypoestrogenism, impaired fertility, and decreased bone mineral density. Women affected may present with normal body weight, complicating early detection and diagnosis. Multidisciplinary management strategies, including lifestyle modification, nutritional support, moderated physical activity, and psychological interventions, have been shown to restore menstrual function and mitigate long-term complications. In selected cases, pharmacological interventions may be necessary to preserve bone health and support reproductive outcomes. Overall, stress-induced menstrual disorders result from a complex interplay between psychological, metabolic, and physical factors, requiring individualized assessment and treatment. Early identification and intervention are essential to prevent chronic health consequences, optimize reproductive potential, and maintain overall well-being. The review highlights gaps in understanding of individual susceptibility, recovery timelines, and long-term metabolic and cognitive outcomes, emphasizing the need for further research to develop targeted preventive and therapeutic strategies for women at risk of stress-related menstrual dysfunction.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessTHE IMPACT OF CHRONIC STRESS ON MENSTRUAL DISORDERS IN WOMEN OF REPRODUCTIVE AGE: A LITERATURE REVIEW
Chronic psychological and physical stress is a major contributor to menstrual disturbances in women of reproductive age. This review aims to synthesize current evidence on the mechanisms, clinical implications, and management of stress-related menstrual dysfunction, with particular focus on hypothalamic suppression. Methods included comprehensive evaluation of observational studies, clinical trials, and experimental research addressing neuroendocrine, metabolic, and behavioral pathways affected by prolonged stress, energy deficiency, and intensive physical activity. Findings indicate that chronic stress disrupts hormonal regulation by inhibiting gonadotropin secretion and impairing ovarian function, leading to reduced estrogen production and anovulation. Energy deficiency and excessive physical exertion exacerbate these effects, resulting in prolonged hypoestrogenism, impaired fertility, and decreased bone mineral density. Women affected may present with normal body weight, complicating early detection and diagnosis. Multidisciplinary management strategies, including lifestyle modification, nutritional support, moderated physical activity, and psychological interventions, have been shown to restore menstrual function and mitigate long-term complications. In selected cases, pharmacological interventions may be necessary to preserve bone health and support reproductive outcomes. Overall, stress-induced menstrual disorders result from a complex interplay between psychological, metabolic, and physical factors, requiring individualized assessment and treatment. Early identification and intervention are essential to prevent chronic health consequences, optimize reproductive potential, and maintain overall well-being. The review highlights gaps in understanding of individual susceptibility, recovery timelines, and long-term metabolic and cognitive outcomes, emphasizing the need for further research to develop targeted preventive and therapeutic strategies for women at risk of stress-related menstrual dysfunction.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
SLEEP DISTURBANCES IN MAJOR DEPRESSIVE DISORDER: A COMPREHENSIVE NARRATIVE REVIEW
Objectives: To review and synthesize current evidence on the characteristics, underlying mechanisms, and clinical significance of sleep disturbances in Major Depressive Disorder (MDD). Methods: A narrative review of thirty peer-reviewed articles published between 2010 and 2025 was conducted. The included studies investigated sleep architecture, circadian rhythms, neurobiological mechanisms, and therapeutic interventions related to sleep disturbances in MDD using neuroimaging, electrophysiological, molecular, and clinical approaches. Results: The reviewed literature indicates that sleep disturbances are a core feature of MDD. The most consistently reported abnormalities include shortened rapid eye movement (REM) latency, reduced slow-wave sleep, and circadian rhythm dysregulation. These alterations are associated with dysfunctions of monoaminergic neurotransmission, hyperactivity of the hypothalamic-pituitary-adrenal axis, and disruptions of circadian clock gene regulation. Sleep disturbances were also linked to impairments in emotional regulation, cognitive functioning, metabolic processes, and treatment response. Sleep-focused interventions, including cognitive-behavioral therapy for insomnia, chronotherapy, and light-based treatments, demonstrated antidepressant effects. Conclusions: Sleep disturbances play a fundamental role in the pathophysiology and clinical course of MDD. Addressing sleep-related mechanisms may improve diagnostic accuracy, enhance treatment effectiveness, and contribute to better long-term outcomes in patients with depression.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessSLEEP DISTURBANCES IN MAJOR DEPRESSIVE DISORDER: A COMPREHENSIVE NARRATIVE REVIEW
Objectives: To review and synthesize current evidence on the characteristics, underlying mechanisms, and clinical significance of sleep disturbances in Major Depressive Disorder (MDD). Methods: A narrative review of thirty peer-reviewed articles published between 2010 and 2025 was conducted. The included studies investigated sleep architecture, circadian rhythms, neurobiological mechanisms, and therapeutic interventions related to sleep disturbances in MDD using neuroimaging, electrophysiological, molecular, and clinical approaches. Results: The reviewed literature indicates that sleep disturbances are a core feature of MDD. The most consistently reported abnormalities include shortened rapid eye movement (REM) latency, reduced slow-wave sleep, and circadian rhythm dysregulation. These alterations are associated with dysfunctions of monoaminergic neurotransmission, hyperactivity of the hypothalamic-pituitary-adrenal axis, and disruptions of circadian clock gene regulation. Sleep disturbances were also linked to impairments in emotional regulation, cognitive functioning, metabolic processes, and treatment response. Sleep-focused interventions, including cognitive-behavioral therapy for insomnia, chronotherapy, and light-based treatments, demonstrated antidepressant effects. Conclusions: Sleep disturbances play a fundamental role in the pathophysiology and clinical course of MDD. Addressing sleep-related mechanisms may improve diagnostic accuracy, enhance treatment effectiveness, and contribute to better long-term outcomes in patients with depression.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
SAFETY AND EFFECTIVENESS OF SSRIS AND SNRIS TREATMENT FOR PERINATAL DEPRESSION: A SYSTEMATIC REVIEW
Introduction and Purpose: Perinatal depression is a common and serious condition affecting maternal and child health. Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs), are widely used despite ongoing safety concerns. This review aims to evaluate current evidence on the safety and effectiveness of antidepressant treatment during pregnancy and the postpartum period to support individualized clinical decision-making in the management of perinatal depression. Methods: A narrative systematic review of population-based cohort studies, systematic reviews, and meta-analyses published between 2014 and 2025 was conducted using PubMed. Results: The evidence indicates that SSRIs and SNRIs exposure during pregnancy is associated with small increases in the risk of preterm birth, neonatal adaptation syndrome, postpartum hemorrhage, and rare outcomes such as persistent pulmonary hypertension of the newborn, particularly with late-pregnancy exposure. Absolute risks remain low, and associations with neurodevelopmental disorders largely attenuate after adjustment for familial and maternal psychiatric factors. Postpartum antidepressant treatment is consistently associated with sustained improvements in maternal mental health and functional outcomes. Conclusions: Current evidence supports individualized risk–benefit assessment when considering antidepressant use during the perinatal period. Maintaining maternal mental health is essential, and treatment decisions should consider illness severity, timing of exposure, and patient preferences.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessSAFETY AND EFFECTIVENESS OF SSRIS AND SNRIS TREATMENT FOR PERINATAL DEPRESSION: A SYSTEMATIC REVIEW
Introduction and Purpose: Perinatal depression is a common and serious condition affecting maternal and child health. Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs), are widely used despite ongoing safety concerns. This review aims to evaluate current evidence on the safety and effectiveness of antidepressant treatment during pregnancy and the postpartum period to support individualized clinical decision-making in the management of perinatal depression. Methods: A narrative systematic review of population-based cohort studies, systematic reviews, and meta-analyses published between 2014 and 2025 was conducted using PubMed. Results: The evidence indicates that SSRIs and SNRIs exposure during pregnancy is associated with small increases in the risk of preterm birth, neonatal adaptation syndrome, postpartum hemorrhage, and rare outcomes such as persistent pulmonary hypertension of the newborn, particularly with late-pregnancy exposure. Absolute risks remain low, and associations with neurodevelopmental disorders largely attenuate after adjustment for familial and maternal psychiatric factors. Postpartum antidepressant treatment is consistently associated with sustained improvements in maternal mental health and functional outcomes. Conclusions: Current evidence supports individualized risk–benefit assessment when considering antidepressant use during the perinatal period. Maintaining maternal mental health is essential, and treatment decisions should consider illness severity, timing of exposure, and patient preferences.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
THE ROLE OF VITAMIN D IN REPRODUCTIVE HEALTH AND INFERTILITY: A REVIEW OF THE LITERATURE
Vitamin D is increasingly recognized as a pleiotropic steroid hormone influencing numerous physiological systems, including reproductive function. Over the past decade, evidence has demonstrated a strong link between vitamin D deficiency and impaired ovarian function, suboptimal endometrial receptivity, reduced sperm quality, and adverse outcomes in assisted reproductive technologies (ART). This comprehensive review synthesizes clinical and mechanistic evidence on the role of vitamin D in female and male infertility, emphasizing ovulation, polycystic ovary syndrome (PCOS), endometrial function, ART outcomes, and male reproductive parameters. Systematic analysis of studies published from 2010 to 2025, including randomized controlled trials, cohort studies, and meta-analyses, shows that sufficient serum 25-hydroxyvitamin D [25(OH)D] levels are associated with improved reproductive parameters, including higher ovulation rates, enhanced implantation, clinical pregnancy, live birth rates, and better sperm quality and motility. Supplementation studies suggest potential benefits in correcting vitamin D deficiency in women with PCOS, women undergoing ART, and men with impaired sperm parameters, although heterogeneity in dosing regimens, baseline populations, and outcome measures limits definitive clinical recommendations. Mechanistic evidence indicates that vitamin D regulates steroidogenesis, endometrial immunomodulation, insulin sensitivity, placental angiogenesis, and spermatogenesis, which may underlie its clinical effects. While current findings support routine assessment and correction of vitamin D deficiency, optimal serum targets, timing, and supplementation protocols require further investigation. Large-scale randomized trials are necessary to establish standardized clinical guidelines and confirm long-term reproductive benefits in both sexes.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessTHE ROLE OF VITAMIN D IN REPRODUCTIVE HEALTH AND INFERTILITY: A REVIEW OF THE LITERATURE
Vitamin D is increasingly recognized as a pleiotropic steroid hormone influencing numerous physiological systems, including reproductive function. Over the past decade, evidence has demonstrated a strong link between vitamin D deficiency and impaired ovarian function, suboptimal endometrial receptivity, reduced sperm quality, and adverse outcomes in assisted reproductive technologies (ART). This comprehensive review synthesizes clinical and mechanistic evidence on the role of vitamin D in female and male infertility, emphasizing ovulation, polycystic ovary syndrome (PCOS), endometrial function, ART outcomes, and male reproductive parameters. Systematic analysis of studies published from 2010 to 2025, including randomized controlled trials, cohort studies, and meta-analyses, shows that sufficient serum 25-hydroxyvitamin D [25(OH)D] levels are associated with improved reproductive parameters, including higher ovulation rates, enhanced implantation, clinical pregnancy, live birth rates, and better sperm quality and motility. Supplementation studies suggest potential benefits in correcting vitamin D deficiency in women with PCOS, women undergoing ART, and men with impaired sperm parameters, although heterogeneity in dosing regimens, baseline populations, and outcome measures limits definitive clinical recommendations. Mechanistic evidence indicates that vitamin D regulates steroidogenesis, endometrial immunomodulation, insulin sensitivity, placental angiogenesis, and spermatogenesis, which may underlie its clinical effects. While current findings support routine assessment and correction of vitamin D deficiency, optimal serum targets, timing, and supplementation protocols require further investigation. Large-scale randomized trials are necessary to establish standardized clinical guidelines and confirm long-term reproductive benefits in both sexes.